© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia
November 14, 2018
Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.
Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.
Related Content:
